Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Factors that determine survival in pulmonary arterial hypertension (PAH) drive clinical
management. A quantitative survival prediction tool has not been established for research
or clinical use.